{
"instance": {
"form10-q.htm": {
"axisCustom": 0,
"axisStandard": 8,
"contextCount": 108,
"dts": {
"calculationLink": {
"local": [
"abmt-20210731_cal.xml"
]
},
"definitionLink": {
"local": [
"abmt-20210731_def.xml"
]
},
"inline": {
"local": [
"form10-q.htm"
]
},
"labelLink": {
"local": [
"abmt-20210731_lab.xml"
],
"remote": [
"https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
]
},
"presentationLink": {
"local": [
"abmt-20210731_pre.xml"
]
},
"referenceLink": {
"remote": [
"https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
]
},
"schema": {
"local": [
"abmt-20210731.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
"https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
"https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
"https://xbrl.sec.gov/country/2021/country-2021.xsd",
"https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
"https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd"
]
}
},
"elementCount": 251,
"entityCount": 1,
"hidden": {
"http://advbiomed.com/20210731": 30,
"http://fasb.org/us-gaap/2021-01-31": 78,
"http://xbrl.sec.gov/dei/2021": 6,
"total": 114
},
"keyCustom": 28,
"keyStandard": 193,
"memberCustom": 8,
"memberStandard": 6,
"nsprefix": "ABMT",
"nsuri": "http://advbiomed.com/20210731",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"b",
"span",
"p",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "00000001 - Document - Cover",
"role": "http://advbiomed.com/role/Cover",
"shortName": "Cover",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"b",
"span",
"p",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ABMT:UseOfEstimatesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000010 - Disclosure - USE OF ESTIMATES",
"role": "http://advbiomed.com/role/UseOfEstimates",
"shortName": "USE OF ESTIMATES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ABMT:UseOfEstimatesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000011 - Disclosure - RELATED PARTY TRANSACTIONS",
"role": "http://advbiomed.com/role/RelatedPartyTransactions",
"shortName": "RELATED PARTY TRANSACTIONS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES",
"role": "http://advbiomed.com/role/CommitmentsAndContingencies",
"shortName": "COMMITMENTS AND CONTINGENCIES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000013 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS",
"role": "http://advbiomed.com/role/FairValueOfFinancialInstruments",
"shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ABMT:RecentAccountingPronouncementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000014 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
"role": "http://advbiomed.com/role/RecentAccountingPronouncements",
"shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ABMT:RecentAccountingPronouncementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000015 - Disclosure - GOING CONCERN",
"role": "http://advbiomed.com/role/GoingConcern",
"shortName": "GOING CONCERN",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
"role": "http://advbiomed.com/role/CommitmentsAndContingenciesTables",
"shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2008-12-31_srt_ParentCompanyMember_custom_ShareExchangeAgreementMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"reportCount": 1,
"unique": true,
"unitRef": "Pure",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000017 - Disclosure - ORGANIZATION (Details Narrative)",
"role": "http://advbiomed.com/role/OrganizationDetailsNarrative",
"shortName": "ORGANIZATION (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2008-12-31_srt_ParentCompanyMember_custom_ShareExchangeAgreementMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"reportCount": 1,
"unique": true,
"unitRef": "Pure",
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"p",
"ABMT:PrinciplesOfConsolidationTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31_srt_ParentCompanyMember_custom_MasteriseHoldingsLimitedMember",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"reportCount": 1,
"unitRef": "Pure",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000018 - Disclosure - PRINCIPLES OF CONSOLIDATION (Details Narrative)",
"role": "http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative",
"shortName": "PRINCIPLES OF CONSOLIDATION (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"p",
"ABMT:PrinciplesOfConsolidationTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31_srt_ParentCompanyMember_custom_ShenzhenChanghuaBiomedicalEngineeringCompanyLimitedMember",
"decimals": "INF",
"lang": null,
"name": "us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners",
"reportCount": 1,
"unique": true,
"unitRef": "Pure",
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "ABMT:DueToStockholderCurrent",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000019 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
"role": "http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative",
"shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": "INF",
"lang": null,
"name": "us-gaap:RelatedPartyTransactionRate",
"reportCount": 1,
"unique": true,
"unitRef": "Pure",
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
"role": "http://advbiomed.com/role/BalanceSheets",
"shortName": "Condensed Consolidated Balance Sheets",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000020 - Disclosure - SCHEDULE OF FUTURE MINIMUM LEASE OBLIGATIONS OF OPERATING LEASES (Details)",
"role": "http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails",
"shortName": "SCHEDULE OF FUTURE MINIMUM LEASE OBLIGATIONS OF OPERATING LEASES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LesseeOperatingLeaseDescription",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000021 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
"role": "http://advbiomed.com/role/CommitmentsAndContingenciesDetailsNarrative",
"shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"p",
"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:LesseeOperatingLeaseDescription",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R22": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:RetainedEarningsAccumulatedDeficit",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000022 - Disclosure - GOING CONCERN (Details Narrative)",
"role": "http://advbiomed.com/role/GoingConcernDetailsNarrative",
"shortName": "GOING CONCERN (Details Narrative)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R3": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unique": true,
"unitRef": "USDPShares",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
"role": "http://advbiomed.com/role/BalanceSheetsParenthetical",
"shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2021-07-31",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unique": true,
"unitRef": "USDPShares",
"xsiNil": "false"
}
},
"R4": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2021-05-012021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
"role": "http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss",
"shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2021-05-012021-07-31",
"decimals": "0",
"lang": null,
"name": "ABMT:CostOfRevenue1",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "AsOf2019-10-31_us-gaap_CommonStockMember",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:StockholdersEquity",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000005 - Statement - Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)",
"role": "http://advbiomed.com/role/StatementsOfStockholdersDeficit",
"shortName": "Condensed Consolidated Statements of Stockholders' Deficit (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2019-11-012020-01-31_us-gaap_RetainedEarningsMember",
"decimals": "0",
"lang": null,
"name": "ABMT:EffectOfAdoptionOfASU",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
"role": "http://advbiomed.com/role/StatementsOfCashFlows",
"shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": "0",
"lang": null,
"name": "us-gaap:DepreciationDepletionAndAmortization",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000007 - Disclosure - BASIS OF PRESENTATION",
"role": "http://advbiomed.com/role/BasisOfPresentation",
"shortName": "BASIS OF PRESENTATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000008 - Disclosure - ORGANIZATION",
"role": "http://advbiomed.com/role/Organization",
"shortName": "ORGANIZATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ABMT:PrinciplesOfConsolidationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00000009 - Disclosure - PRINCIPLES OF CONSOLIDATION",
"role": "http://advbiomed.com/role/PrinciplesOfConsolidation",
"shortName": "PRINCIPLES OF CONSOLIDATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"body",
"html"
],
"baseRef": "form10-q.htm",
"contextRef": "From2020-11-01to2021-07-31",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "ABMT:PrinciplesOfConsolidationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 15,
"tag": {
"ABMT_CostOfRevenue1": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_GrossProfit",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
"label": "CostOfRevenue1",
"negatedLabel": "Cost of sales"
}
}
},
"localname": "CostOfRevenue1",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"ABMT_DepreciationOnOperatingLeaseRightofuseAssets": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 4.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Depreciation on operating lease right of use assets.",
"label": "Depreciation on operating lease right-of-use assets"
}
}
},
"localname": "DepreciationOnOperatingLeaseRightofuseAssets",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"ABMT_DepreciationOnOperatingLeasesRightofuseAssets": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Depreciation on operating lease right-of-use assets.",
"label": "Depreciation on operating lease right-of-use assets [Default Label]",
"verboseLabel": "Depreciation on operating lease right-of-use assets"
}
}
},
"localname": "DepreciationOnOperatingLeasesRightofuseAssets",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_DisclosurePrinciplesOfConsolidationAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Principles Of Consolidation"
}
}
},
"localname": "DisclosurePrinciplesOfConsolidationAbstract",
"nsuri": "http://advbiomed.com/20210731",
"xbrltype": "stringItemType"
},
"ABMT_DisclosureRecentAccountingPronouncementsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Recent Accounting Pronouncements"
}
}
},
"localname": "DisclosureRecentAccountingPronouncementsAbstract",
"nsuri": "http://advbiomed.com/20210731",
"xbrltype": "stringItemType"
},
"ABMT_DisclosureUseOfEstimatesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Use Of Estimates"
}
}
},
"localname": "DisclosureUseOfEstimatesAbstract",
"nsuri": "http://advbiomed.com/20210731",
"xbrltype": "stringItemType"
},
"ABMT_DueToOfficersCurrent": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amounts due to recorded owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Due to directors"
}
}
},
"localname": "DueToOfficersCurrent",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"ABMT_DueToStockholderCurrent": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 5.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of obligations due stockholders. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Due to a stockholder",
"verboseLabel": "Due to stockholder"
}
}
},
"localname": "DueToStockholderCurrent",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"ABMT_EffectOfAdoptionOfASU": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Effect of adoption of ASU 2016-02.",
"label": "Effect of adoption of ASU 2016-02"
}
}
},
"localname": "EffectOfAdoptionOfASU",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"ABMT_FourFelatedPartiesMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Four Related Parties [Member].",
"label": "Four Related Parties [Member]"
}
}
},
"localname": "FourFelatedPartiesMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_GovernmentGrants": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Government grants.",
"label": "GovernmentGrants",
"negatedLabel": "Government grants"
}
}
},
"localname": "GovernmentGrants",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"ABMT_ImputedInterestOnAdvancesFromDirectors": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Imputed interest on advances from directors.",
"label": "Imputed interest on advances from directors"
}
}
},
"localname": "ImputedInterestOnAdvancesFromDirectors",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"ABMT_ImputedInterestRate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Imputed interest rate.",
"label": "Imputed interest rate"
}
}
},
"localname": "ImputedInterestRate",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"ABMT_IncreaseDecreaseInDepreciationAllocatedToInventory": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Increase decrease in depreciation allocated to inventory.",
"label": "Depreciation allocated to inventory"
}
}
},
"localname": "IncreaseDecreaseInDepreciationAllocatedToInventory",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_InterestExpenses": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Other non cash interest expenses.",
"label": "Interest expenses"
}
}
},
"localname": "InterestExpenses",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_InterestOnCarLoan": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Interest on car loan.",
"label": "InterestOnCarLoan",
"negatedLabel": "Interest on car loan"
}
}
},
"localname": "InterestOnCarLoan",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_InterestOnCarLoans": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Interest on car loans.",
"label": "Interest on car loans"
}
}
},
"localname": "InterestOnCarLoans",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_InterestOnOperatingLeaseLiabilities": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 5.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Interest on operating lease liabilities.",
"label": "InterestOnOperatingLeaseLiabilities",
"negatedLabel": "Interest on operating lease liabilities"
}
}
},
"localname": "InterestOnOperatingLeaseLiabilities",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"ABMT_InterestOnOperatingLeasesLiabilities": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Interest on operating lease liabilities.",
"label": "Interest on operating lease liabilities"
}
}
},
"localname": "InterestOnOperatingLeasesLiabilities",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_LeaseOfLowvalueAssetsNotCapitalised": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Lease of low-value assets not capitalised.",
"label": "Lease of low-value assets not capitalized"
}
}
},
"localname": "LeaseOfLowvalueAssetsNotCapitalised",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"ABMT_MasteriseHoldingsLimitedMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Masterise [Member]",
"label": "Masterise [Member]"
}
}
},
"localname": "MasteriseHoldingsLimitedMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_MasteriseMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of investment.",
"label": "Masterise [Member] [Default Label]",
"verboseLabel": "Masterise [Member]"
}
}
},
"localname": "MasteriseMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_MrChenTieJunMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Mr Chen Tie Jun [Member]"
}
}
},
"localname": "MrChenTieJunMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_NetExchangeDifference": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Net exchange difference.",
"label": "Net exchange difference"
}
}
},
"localname": "NetExchangeDifference",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_PaymentsOfProceedsFromInterestElementOfOperatingLeasePayments": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Principal element of operating lease payments.",
"label": "PaymentsOfProceedsFromInterestElementOfOperatingLeasePayments",
"negatedLabel": "Interest element of operating lease payments"
}
}
},
"localname": "PaymentsOfProceedsFromInterestElementOfOperatingLeasePayments",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_PaymentsOfProceedsFromPrincipalElementOfOperatingLeasePayments": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Interest element of operating lease payments.",
"label": "PaymentsOfProceedsFromPrincipalElementOfOperatingLeasePayments",
"negatedLabel": "Principal element of operating lease payments"
}
}
},
"localname": "PaymentsOfProceedsFromPrincipalElementOfOperatingLeasePayments",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_PrinciplesOfConsolidationTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Principles of Consolidation [Text Block]",
"label": "PRINCIPLES OF CONSOLIDATION"
}
}
},
"localname": "PrinciplesOfConsolidationTextBlock",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/PrinciplesOfConsolidation"
],
"xbrltype": "textBlockItemType"
},
"ABMT_ProceedsFromDirectors": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Due to directors.",
"label": "ProceedsFromDirectors",
"verboseLabel": "Due to directors"
}
}
},
"localname": "ProceedsFromDirectors",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_ProceedsFromStockholder": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Due to a stockholder,",
"label": "ProceedsFromStockholder",
"verboseLabel": "Due to a stockholder"
}
}
},
"localname": "ProceedsFromStockholder",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"ABMT_RecentAccountingPronouncementsDisclosureTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Recent Accounting Pronouncements [Disclosure Text Block]",
"label": "RECENT ACCOUNTING PRONOUNCEMENTS"
}
}
},
"localname": "RecentAccountingPronouncementsDisclosureTextBlock",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/RecentAccountingPronouncements"
],
"xbrltype": "textBlockItemType"
},
"ABMT_ShareExchangeAgreementMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Share Exchange Agreement [Member].",
"label": "Share Exchange Agreement [Member]"
}
}
},
"localname": "ShareExchangeAgreementMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_SharePurchaseAgreementMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Share Purchase Agreement [Member].",
"label": "Share Purchase Agreement [Member]"
}
}
},
"localname": "SharePurchaseAgreementMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_ShenzhenChanghuaBiomedicalEngineeringCompanyLimitedMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Shenzhen Changhua [Member]",
"label": "Shenzhen Changhua [Member]"
}
}
},
"localname": "ShenzhenChanghuaBiomedicalEngineeringCompanyLimitedMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"ABMT_ShorttermLeaseNotRecognizedAsLiability": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Short-term lease not recognized as a liability.",
"label": "ShorttermLeaseNotRecognizedAsLiability",
"negatedLabel": "Short-term lease not recognized as a liability"
}
}
},
"localname": "ShorttermLeaseNotRecognizedAsLiability",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"ABMT_StockBasedCompensationReserveMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Stock-based Compensation Reserve [Member]",
"label": "Stock-based Compensation Reserve [Member]"
}
}
},
"localname": "StockBasedCompensationReserveMember",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "domainItemType"
},
"ABMT_StockbasedCompensationReserves": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Stock-based compensation reserves.",
"label": "Stock-based compensation reserves"
}
}
},
"localname": "StockbasedCompensationReserves",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"ABMT_UseOfEstimatesTextBlock": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Use of Estimates [Text Block]",
"label": "USE OF ESTIMATES"
}
}
},
"localname": "UseOfEstimatesTextBlock",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/UseOfEstimates"
],
"xbrltype": "textBlockItemType"
},
"ABMT_WeightedAverageNumberOfSharesVestedNotIssuedBasic": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Weighted average number of shares vested but not issued, basic",
"label": "Weighted average number of shares outstanding during the period - vested, but not yet issued"
}
}
},
"localname": "WeightedAverageNumberOfSharesVestedNotIssuedBasic",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "sharesItemType"
},
"ABMT_WorkingCapitalDeficit": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Working capital deficit.",
"label": "Working capital deficit"
}
}
},
"localname": "WorkingCapitalDeficit",
"nsuri": "http://advbiomed.com/20210731",
"presentation": [
"http://advbiomed.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"dei_AmendmentDescription": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Description of changes contained within amended document.",
"label": "Amendment Description"
}
}
},
"localname": "AmendmentDescription",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "stringItemType"
},
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_AnnualInformationForm": {
"auth_ref": [
"r280"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
"label": "Annual Information Form"
}
}
},
"localname": "AnnualInformationForm",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_AuditedAnnualFinancialStatements": {
"auth_ref": [
"r280"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
"label": "Audited Annual Financial Statements"
}
}
},
"localname": "AuditedAnnualFinancialStatements",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CountryRegion": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Region code of country",
"label": "Country Region"
}
}
},
"localname": "CountryRegion",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Cover page.",
"label": "Cover [Abstract]"
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"xbrltype": "stringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentAccountingStandard": {
"auth_ref": [
"r279"
],
"lang": {
"en-us": {
"role": {
"documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
"label": "Document Accounting Standard"
}
}
},
"localname": "DocumentAccountingStandard",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "accountingStandardItemType"
},
"dei_DocumentAnnualReport": {
"auth_ref": [
"r277",
"r279",
"r280"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an annual report.",
"label": "Document Annual Report"
}
}
},
"localname": "DocumentAnnualReport",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.",
"label": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "dateItemType"
},
"dei_DocumentPeriodStartDate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
"label": "Document Period Start Date"
}
}
},
"localname": "DocumentPeriodStartDate",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r278"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentRegistrationStatement": {
"auth_ref": [
"r286"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a registration statement.",
"label": "Document Registration Statement"
}
}
},
"localname": "DocumentRegistrationStatement",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentShellCompanyEventDate": {
"auth_ref": [
"r279"
],
"lang": {
"en-us": {
"role": {
"documentation": "Date of event requiring a shell company report.",
"label": "Document Shell Company Event Date"
}
}
},
"localname": "DocumentShellCompanyEventDate",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "dateItemType"
},
"dei_DocumentShellCompanyReport": {
"auth_ref": [
"r279"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
"label": "Document Shell Company Report"
}
}
},
"localname": "DocumentShellCompanyReport",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r281"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "submissionTypeItemType"
},
"dei_DocumentsIncorporatedByReferenceTextBlock": {
"auth_ref": [
"r269"
],
"lang": {
"en-us": {
"role": {
"documentation": "Documents incorporated by reference.",
"label": "Documents Incorporated by Reference [Text Block]"
}
}
},
"localname": "DocumentsIncorporatedByReferenceTextBlock",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "textBlockItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine2": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 2 such as Street or Suite number",
"label": "Entity Address, Address Line Two"
}
}
},
"localname": "EntityAddressAddressLine2",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine3": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 3 such as an Office Park",
"label": "Entity Address, Address Line Three"
}
}
},
"localname": "EntityAddressAddressLine3",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCountry": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "ISO 3166-1 alpha-2 country code.",
"label": "Entity Address, Country"
}
}
},
"localname": "EntityAddressCountry",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "countryCodeItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityBankruptcyProceedingsReportingCurrent": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
"label": "Entity Bankruptcy Proceedings, Reporting Current"
}
}
},
"localname": "EntityBankruptcyProceedingsReportingCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityExTransitionPeriod": {
"auth_ref": [
"r285"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
"label": "Elected Not To Use the Extended Transition Period"
}
}
},
"localname": "EntityExTransitionPeriod",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r283"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityPrimarySicNumber": {
"auth_ref": [
"r280"
],
"lang": {
"en-us": {
"role": {
"documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
"label": "Entity Primary SIC Number"
}
}
},
"localname": "EntityPrimarySicNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "sicNumberItemType"
},
"dei_EntityPublicFloat": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
"label": "Entity Public Float"
}
}
},
"localname": "EntityPublicFloat",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "monetaryItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r282"
],
"lang": {
"en-us": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "employerIdItemType"
},
"dei_EntityVoluntaryFilers": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
"label": "Entity Voluntary Filers"
}
}
},
"localname": "EntityVoluntaryFilers",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityWellKnownSeasonedIssuer": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
"label": "Entity Well-known Seasoned Issuer"
}
}
},
"localname": "EntityWellKnownSeasonedIssuer",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "yesNoItemType"
},
"dei_Extension": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Extension number for local phone number.",
"label": "Extension"
}
}
},
"localname": "Extension",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "normalizedStringItemType"
},
"dei_NoTradingSymbolFlag": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a security having no trading symbol.",
"label": "No Trading Symbol Flag"
}
}
},
"localname": "NoTradingSymbolFlag",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_OtherReportingStandardItemNumber": {
"auth_ref": [
"r279"
],
"lang": {
"en-us": {
"role": {
"documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
"label": "Other Reporting Standard Item Number"
}
}
},
"localname": "OtherReportingStandardItemNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "otherReportingStandardItemNumberItemType"
},
"dei_PreCommencementIssuerTenderOffer": {
"auth_ref": [
"r273"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
"label": "Pre-commencement Issuer Tender Offer"
}
}
},
"localname": "PreCommencementIssuerTenderOffer",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_PreCommencementTenderOffer": {
"auth_ref": [
"r274"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
"label": "Pre-commencement Tender Offer"
}
}
},
"localname": "PreCommencementTenderOffer",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r268"
],
"lang": {
"en-us": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "securityTitleItemType"
},
"dei_Security12gTitle": {
"auth_ref": [
"r271"
],
"lang": {
"en-us": {
"role": {
"documentation": "Title of a 12(g) registered security.",
"label": "Title of 12(g) Security"
}
}
},
"localname": "Security12gTitle",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r270"
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_SecurityReportingObligation": {
"auth_ref": [
"r275"
],
"lang": {
"en-us": {
"role": {
"documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
"label": "Security Reporting Obligation"
}
}
},
"localname": "SecurityReportingObligation",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "securityReportingObligationItemType"
},
"dei_SolicitingMaterial": {
"auth_ref": [
"r276"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
"label": "Soliciting Material"
}
}
},
"localname": "SolicitingMaterial",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"dei_TradingSymbol": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "tradingSymbolItemType"
},
"dei_WrittenCommunications": {
"auth_ref": [
"r284"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
"label": "Written Communications"
}
}
},
"localname": "WrittenCommunications",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://advbiomed.com/role/Cover"
],
"xbrltype": "booleanItemType"
},
"srt_CondensedCashFlowStatementsCaptionsLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Condensed Cash Flow Statements, Captions [Line Items]"
}
}
},
"localname": "CondensedCashFlowStatementsCaptionsLineItems",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"srt_ConsolidatedEntitiesAxis": {
"auth_ref": [
"r78",
"r133",
"r138",
"r144",
"r178",
"r179",
"r186",
"r187",
"r218",
"r266"
],
"lang": {
"en-us": {
"role": {
"label": "Consolidated Entities [Axis]"
}
}
},
"localname": "ConsolidatedEntitiesAxis",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"srt_ConsolidatedEntitiesDomain": {
"auth_ref": [
"r78",
"r133",
"r138",
"r144",
"r178",
"r179",
"r186",
"r187",
"r218",
"r266"
],
"localname": "ConsolidatedEntitiesDomain",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_EquityMethodInvesteeNameDomain": {
"auth_ref": [
],
"localname": "EquityMethodInvesteeNameDomain",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_OwnershipAxis": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Ownership [Axis]"
}
}
},
"localname": "OwnershipAxis",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"srt_OwnershipDomain": {
"auth_ref": [
],
"localname": "OwnershipDomain",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_ParentCompanyMember": {
"auth_ref": [
"r78"
],
"lang": {
"en-us": {
"role": {
"label": "Parent Company [Member]"
}
}
},
"localname": "ParentCompanyMember",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
"auth_ref": [
"r121"
],
"lang": {
"en-us": {
"role": {
"label": "Investment, Name [Axis]"
}
}
},
"localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
"nsuri": "http://fasb.org/srt/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"auth_ref": [
"r30"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Trade payables and contract liabilities"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
"auth_ref": [
"r28",
"r126"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
"label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
"negatedLabel": "Less: Accumulated depreciation"
}
}
},
"localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r20",
"r37",
"r38",
"r39",
"r249",
"r263",
"r264"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 5.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
"label": "Accumulated other comprehensive income/(loss)"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
"auth_ref": [
"r36",
"r39",
"r46",
"r47",
"r48",
"r80",
"r81",
"r82",
"r184",
"r259",
"r260",
"r287"
],
"lang": {
"en-us": {
"role": {
"documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
"label": "AOCI Attributable to Parent [Member]"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdditionalPaidInCapitalCommonStock": {
"auth_ref": [
"r18"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
"label": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapitalCommonStock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
"r80",
"r81",
"r82",
"r159",
"r160",
"r161",
"r192"
],
"lang": {
"en-us": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-in Capital [Member]"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
"auth_ref": [
"r157",
"r158",
"r163",
"r164"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
"label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
"verboseLabel": "Stock-based compensation expenses"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Adjustments to reconcile net loss to cash used in operating activities"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
}
}
},
"localname": "ArrangementsAndNonarrangementTransactionsMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r75",
"r107",
"r110",
"r115",
"r122",
"r133",
"r134",
"r135",
"r137",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r178",
"r186",
"r195",
"r219",
"r221",
"r237",
"r248"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "TOTAL ASSETS"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "ASSETS"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r6",
"r7",
"r35",
"r75",
"r122",
"r133",
"r134",
"r135",
"r137",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r178",
"r186",
"r195",
"r219",
"r221"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total current assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CURRENT ASSETS"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsNoncurrent": {
"auth_ref": [
"r8",
"r9",
"r10",
"r11",
"r12",
"r13",
"r14",
"r15",
"r75",
"r122",
"r133",
"r134",
"r135",
"r137",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r178",
"r186",
"r195",
"r219"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
"label": "Assets, Noncurrent",
"totalLabel": "Total non-current assets"
}
}
},
"localname": "AssetsNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsNoncurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "NON-CURRENT ASSETS"
}
}
},
"localname": "AssetsNoncurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionAcquireeDomain": {
"auth_ref": [
"r155",
"r156"
],
"lang": {
"en-us": {
"role": {
"documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
}
}
},
"localname": "BusinessAcquisitionAcquireeDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAxis": {
"auth_ref": [
"r155",
"r156",
"r172",
"r173"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by business combination or series of individually immaterial business combinations.",
"label": "Business Acquisition [Axis]"
}
}
},
"localname": "BusinessAcquisitionAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
"auth_ref": [
"r171"
],
"lang": {
"en-us": {
"role": {
"documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
"label": "Business Acquisition, Percentage of Voting Interests Acquired",
"verboseLabel": "Ownership acquired"
}
}
},
"localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
"auth_ref": [
"r3",
"r79",
"r100"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "BASIS OF PRESENTATION"
}
}
},
"localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BasisOfPresentation"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Capital": {
"auth_ref": [
"r247"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of total capital as defined by regulatory framework.",
"label": "Registered capital"
}
}
},
"localname": "Capital",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsAtCarryingValue": {
"auth_ref": [
"r4",
"r26",
"r72"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash and cash equivalents"
}
}
},
"localname": "CashAndCashEquivalentsAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
"auth_ref": [
"r66",
"r72",
"r74"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
"periodEndLabel": "CASH AND CASH EQUIVALENTS AT THE END OF PERIOD",
"periodStartLabel": "CASH AND CASH EQUIVALENTS AT THE BEGINNING OF PERIOD"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
"auth_ref": [
"r66",
"r196"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
"totalLabel": "INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CommitmentsAndContingencies": {
"auth_ref": [
"r32",
"r131",
"r239",
"r253"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
"label": "Outstanding commitment"
}
}
},
"localname": "CommitmentsAndContingencies",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Commitments and Contingencies Disclosure [Abstract]"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
"auth_ref": [
"r128",
"r129",
"r130",
"r132",
"r265"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for commitments and contingencies.",
"label": "COMMITMENTS AND CONTINGENCIES"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/CommitmentsAndContingencies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
"r80",
"r81",
"r192"
],
"lang": {
"en-us": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r17"
],
"lang": {
"en-us": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common stock, par value"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheetsParenthetical"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r17"
],
"lang": {
"en-us": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common stock, shares authorized"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r17"
],
"lang": {
"en-us": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common stock, shares issued"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r17",
"r150"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common stock, shares outstanding"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheetsParenthetical"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r17",
"r221"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common stock, $0.00001 par value, 100,000,000 shares authorized, 70,224,850 issued and outstanding as of July 31, 2021 and October 31, 2020"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTax": {
"auth_ref": [
"r42",
"r44",
"r45",
"r54",
"r243",
"r256"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
"totalLabel": "COMPREHENSIVE LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS"
}
}
},
"localname": "ComprehensiveIncomeNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "OTHER COMPREHENSIVE LOSS"
}
}
},
"localname": "ComprehensiveIncomeNetOfTaxAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "stringItemType"
},
"us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
}
}
},
"localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
"auth_ref": [
"r185",
"r190"
],
"lang": {
"en-us": {
"role": {
"documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
"label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
}
}
},
"localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_Depreciation": {
"auth_ref": [
"r70",
"r124"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 3.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
"label": "Depreciation on property and equipment"
}
}
},
"localname": "Depreciation",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DepreciationDepletionAndAmortization": {
"auth_ref": [
"r70",
"r105"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
"label": "Depreciation on property & equipment"
}
}
},
"localname": "DepreciationDepletionAndAmortization",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DueToRelatedPartiesCurrent": {
"auth_ref": [
"r29",
"r77",
"r136",
"r138",
"r139",
"r143",
"r144",
"r145",
"r213"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 6.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Advances from related parties",
"verboseLabel": "Due to related parties"
}
}
},
"localname": "DueToRelatedPartiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EarningsPerShareBasicAndDiluted": {
"auth_ref": [
"r96"
],
"lang": {
"en-us": {
"role": {
"documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Net loss per share-basic and diluted - basic and diluted"
}
}
},
"localname": "EarningsPerShareBasicAndDiluted",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
"auth_ref": [
"r196"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS"
}
}
},
"localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r0",
"r46",
"r47",
"r48",
"r80",
"r81",
"r82",
"r84",
"r89",
"r91",
"r98",
"r123",
"r150",
"r151",
"r159",
"r160",
"r161",
"r167",
"r168",
"r192",
"r197",
"r198",
"r199",
"r200",
"r201",
"r203",
"r259",
"r260",
"r261",
"r287"
],
"lang": {
"en-us": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityMethodInvestmentOwnershipPercentage": {
"auth_ref": [
"r121"
],
"lang": {
"en-us": {
"role": {
"documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
"label": "Ownership acquired",
"verboseLabel": "Equity method investment ownership percentage"
}
}
},
"localname": "EquityMethodInvestmentOwnershipPercentage",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_FairValueDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value Disclosures [Abstract]"
}
}
},
"localname": "FairValueDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresTextBlock": {
"auth_ref": [
"r194"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
"label": "FAIR VALUE OF FINANCIAL INSTRUMENTS"
}
}
},
"localname": "FairValueDisclosuresTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/FairValueOfFinancialInstruments"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
"auth_ref": [
"r70"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
"label": "Gain (Loss) on Disposition of Property Plant Equipment",
"negatedLabel": "Loss on disposal of property and equipment"
}
}
},
"localname": "GainLossOnSaleOfPropertyPlantEquipment",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GeneralAndAdministrativeExpense": {
"auth_ref": [
"r56"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
"label": "General and administrative expenses"
}
}
},
"localname": "GeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GrossProfit": {
"auth_ref": [
"r55",
"r75",
"r107",
"r109",
"r111",
"r114",
"r116",
"r122",
"r133",
"r134",
"r135",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r195"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
"label": "Gross Profit",
"totalLabel": "Gross margin"
}
}
},
"localname": "GrossProfit",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
"auth_ref": [
"r51",
"r107",
"r109",
"r111",
"r114",
"r116",
"r236",
"r240",
"r245",
"r257"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
"label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
"totalLabel": "LOSS BEFORE TAXES"
}
}
},
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r76",
"r90",
"r91",
"r106",
"r166",
"r169",
"r170",
"r258"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income tax expense"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r69"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 13.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
"label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
"verboseLabel": "Trade payables and contract liabilities"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInInventories": {
"auth_ref": [
"r69"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
"label": "Increase (Decrease) in Inventories",
"negatedLabel": "Inventory"
}
}
},
"localname": "IncreaseDecreaseInInventories",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Changes in operating assets and liabilities (Increase)/Decrease in:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Increase/(Decrease) in:"
}
}
},
"localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r69"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 14.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
"label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
"verboseLabel": "Other payables and accrued expenses"
}
}
},
"localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
"auth_ref": [
"r69"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
"label": "Increase (Decrease) in Prepaid Expense and Other Assets",
"negatedLabel": "Other receivables and prepaid expenses"
}
}
},
"localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpense": {
"auth_ref": [
"r50",
"r104",
"r204",
"r205",
"r244"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
"label": "Imputed interest"
}
}
},
"localname": "InterestExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpenseDebt": {
"auth_ref": [
"r59",
"r146",
"r147",
"r148",
"r149"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 6.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
"label": "Imputed interests",
"negatedLabel": "Imputed interest"
}
}
},
"localname": "InterestExpenseDebt",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative",
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpenseOther": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 4.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of interest expense classified as other.",
"label": "Interest Expense, Other",
"negatedLabel": "Interest on car loan"
}
}
},
"localname": "InterestExpenseOther",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpenseRelatedParty": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 3.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of interest expense incurred on a debt or other obligation to related party.",
"label": "Interest expenses on advances from stockholder and related parties",
"negatedLabel": "Interest paid to a stockholder and related parties"
}
}
},
"localname": "InterestExpenseRelatedParty",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative",
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestPaidNet": {
"auth_ref": [
"r64",
"r67",
"r73"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
"label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
"verboseLabel": "Interest income"
}
}
},
"localname": "InterestPaidNet",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InventoryNet": {
"auth_ref": [
"r5",
"r34",
"r221"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
"label": "Inventory"
}
}
},
"localname": "InventoryNet",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InvestmentIncomeInterest": {
"auth_ref": [
"r57",
"r103"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
"label": "Interest income"
}
}
},
"localname": "InvestmentIncomeInterest",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LesseeOperatingLeaseDescription": {
"auth_ref": [
"r208"
],
"lang": {
"en-us": {
"role": {
"documentation": "Description of lessee's operating lease.",
"label": "Operating lease, description"
}
}
},
"localname": "LesseeOperatingLeaseDescription",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
"auth_ref": [
"r209"
],
"lang": {
"en-us": {
"role": {
"documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
"label": "SCHEDULE OF FUTURE MINIMUM LEASE OBLIGATIONS OF OPERATING LEASES"
}
}
},
"localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/CommitmentsAndContingenciesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
"auth_ref": [
"r209"
],
"calculation": {
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
"label": "Lessee, Operating Lease, Liability, to be Paid",
"totalLabel": "Total lease payment payables"
}
}
},
"localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
"auth_ref": [
"r209"
],
"calculation": {
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails": {
"order": 2.0,
"parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
"label": "2022"
}
}
},
"localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
"auth_ref": [
"r209"
],
"calculation": {
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails": {
"order": 1.0,
"parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
"label": "2021"
}
}
},
"localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
"auth_ref": [
"r209"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
"label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
"negatedLabel": "Less: Interest element"
}
}
},
"localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r23",
"r75",
"r122",
"r195",
"r221",
"r238",
"r251"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r31",
"r75",
"r122",
"r133",
"r134",
"r135",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r179",
"r186",
"r187",
"r195",
"r219",
"r220",
"r221"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"totalLabel": "Total current liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CURRENT LIABILITIES"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesNoncurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "NON-CURRENT LIABILITIES"
}
}
},
"localname": "LiabilitiesNoncurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": {
"auth_ref": [
"r99"
],
"lang": {
"en-us": {
"role": {
"documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).",
"label": "Ownership interest - majority stockholder"
}
}
},
"localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": {
"auth_ref": [
"r99"
],
"lang": {
"en-us": {
"role": {
"documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).",
"label": "Ownership interest - minority stockholder"
}
}
},
"localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_MajorityShareholderMember": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Owner that controls more than 50 percent of the voting interest in the entity through direct or indirect ownership.",
"label": "Majority Shareholder [Member]"
}
}
},
"localname": "MajorityShareholderMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
"label": "Ownership by non-controlling stockholders"
}
}
},
"localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r66"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM FINANCING ACTIVITIES"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r66"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Net Cash Provided by (Used in) Investing Activities",
"totalLabel": "Net cash used in investing activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM INVESTING ACTIVITIES"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r66",
"r68",
"r71"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"negatedLabel": "Net cash generated used in in operating activities",
"totalLabel": "Net cash used in operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/GoingConcernDetailsNarrative",
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM OPERATING ACTIVITIES"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r1",
"r40",
"r43",
"r48",
"r52",
"r71",
"r75",
"r83",
"r85",
"r86",
"r87",
"r88",
"r90",
"r91",
"r95",
"r107",
"r109",
"r111",
"r114",
"r116",
"r122",
"r133",
"r134",
"r135",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r193",
"r195",
"r241",
"r254"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net loss",
"totalLabel": "NET LOSS ATTRIBUTABLE TO ABMT COMMON STOCKHOLDERS",
"verboseLabel": "Net loss attributable to ABMT common stockholders"
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows",
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss",
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
"auth_ref": [
"r40",
"r43",
"r48",
"r90",
"r91",
"r181",
"r188"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
"label": "Net loss attributable to non-controlling interests"
}
}
},
"localname": "NetIncomeLossAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Other non cash items"
}
}
},
"localname": "NoncashInvestingAndFinancingItemsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_NonoperatingIncomeExpense": {
"auth_ref": [
"r58"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
"label": "Nonoperating Income (Expense)",
"totalLabel": "Total Other Expenses, net"
}
}
},
"localname": "NonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NonoperatingIncomeExpenseAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "OTHER (EXPENSES) INCOME"
}
}
},
"localname": "NonoperatingIncomeExpenseAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingExpenses": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
"label": "Operating Expenses",
"totalLabel": "Total Operating Expenses"
}
}
},
"localname": "OperatingExpenses",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingExpensesAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "OPERATING EXPENSES"
}
}
},
"localname": "OperatingExpensesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "stringItemType"
},
"us-gaap_OperatingIncomeLoss": {
"auth_ref": [
"r107",
"r109",
"r111",
"r114",
"r116"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The net result for the period of deducting operating expenses from operating revenues.",
"label": "Operating Income (Loss)",
"totalLabel": "LOSS FROM OPERATIONS"
}
}
},
"localname": "OperatingIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLiability": {
"auth_ref": [
"r207"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
"label": "Total lease liabilities"
}
}
},
"localname": "OperatingLeaseLiability",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLiabilityCurrent": {
"auth_ref": [
"r207"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
"label": "Operating lease liabilities, current portion",
"negatedLabel": "Lease liabilities, current portion"
}
}
},
"localname": "OperatingLeaseLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLiabilityNoncurrent": {
"auth_ref": [
"r207"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
"label": "Operating lease liabilities, less current portion",
"verboseLabel": "Lease liabilities, non-current portion"
}
}
},
"localname": "OperatingLeaseLiabilityNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/ScheduleOfFutureMinimumLeaseObligationsOfOperatingLeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseRightOfUseAsset": {
"auth_ref": [
"r206"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_AssetsNoncurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of lessee's right to use underlying asset under operating lease.",
"label": "Operating lease right-of-use assets"
}
}
},
"localname": "OperatingLeaseRightOfUseAsset",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
"auth_ref": [
"r3",
"r191"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
"label": "ORGANIZATION"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/Organization"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.",
"label": "Other payables and accrued expenses"
}
}
},
"localname": "OtherAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
"auth_ref": [
"r176",
"r177",
"r183"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
"label": "Foreign currency translation loss",
"verboseLabel": "Foreign currency translation gain (loss)"
}
}
},
"localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss",
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r41",
"r44",
"r46",
"r47",
"r49",
"r53",
"r150",
"r197",
"r202",
"r203",
"r242",
"r255"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
"label": "Other Comprehensive Income (Loss), Net of Tax",
"totalLabel": "Total other comprehensive loss"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherNonoperatingIncomeExpense": {
"auth_ref": [
"r60"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 7.0,
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
"label": "Other, net"
}
}
},
"localname": "OtherNonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesGross": {
"auth_ref": [
"r61",
"r174"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
"label": "Payment for acquisition"
}
}
},
"localname": "PaymentsToAcquireBusinessesGross",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
"auth_ref": [
"r62"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
"label": "Payments to Acquire Property, Plant, and Equipment",
"negatedLabel": "Purchase of property and equipment"
}
}
},
"localname": "PaymentsToAcquirePropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
"auth_ref": [
"r6",
"r24",
"r25"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
"label": "Other receivables and prepaid expenses"
}
}
},
"localname": "PrepaidExpenseAndOtherAssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromRelatedPartyDebt": {
"auth_ref": [
"r63"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
"label": "Due to related parties"
}
}
},
"localname": "ProceedsFromRelatedPartyDebt",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProfitLoss": {
"auth_ref": [
"r1",
"r40",
"r43",
"r48",
"r65",
"r75",
"r83",
"r90",
"r91",
"r107",
"r109",
"r111",
"r114",
"r116",
"r122",
"r133",
"r134",
"r135",
"r138",
"r139",
"r140",
"r141",
"r142",
"r144",
"r145",
"r176",
"r180",
"r182",
"r188",
"r189",
"r193",
"r195",
"r245"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
"label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
"negatedLabel": "Net loss",
"totalLabel": "NET LOSS"
}
}
},
"localname": "ProfitLoss",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/GoingConcernDetailsNarrative",
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentGross": {
"auth_ref": [
"r27",
"r125"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property and equipment, cost"
}
}
},
"localname": "PropertyPlantAndEquipmentGross",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentNet": {
"auth_ref": [
"r11",
"r12",
"r127",
"r221",
"r246",
"r252"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 1.0,
"parentTag": "us-gaap_AssetsNoncurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment, Net",
"totalLabel": "Property and equipment, net"
}
}
},
"localname": "PropertyPlantAndEquipmentNet",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyDomain": {
"auth_ref": [
"r154",
"r212",
"r213"
],
"lang": {
"en-us": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"localname": "RelatedPartyDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyTransactionAxis": {
"auth_ref": [
"r154",
"r212",
"r213",
"r215"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by type of related party transaction.",
"label": "Related Party Transaction [Axis]"
}
}
},
"localname": "RelatedPartyTransactionAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionDomain": {
"auth_ref": [
"r154"
],
"lang": {
"en-us": {
"role": {
"documentation": "Transaction between related party."
}
}
},
"localname": "RelatedPartyTransactionDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative",
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyTransactionLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Related Party Transaction [Line Items]"
}
}
},
"localname": "RelatedPartyTransactionLineItems",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionRate": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
"label": "Interest rate"
}
}
},
"localname": "RelatedPartyTransactionRate",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "percentItemType"
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transactions [Abstract]"
}
}
},
"localname": "RelatedPartyTransactionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"auth_ref": [
"r154",
"r212",
"r215",
"r224",
"r225",
"r226",
"r227",
"r228",
"r229",
"r230",
"r231",
"r232",
"r233",
"r234",
"r235"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party [Axis]"
}
}
},
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"auth_ref": [
"r210",
"r211",
"r213",
"r216",
"r217"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "RELATED PARTY TRANSACTIONS"
}
}
},
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactions"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ResearchAndDevelopmentExpense": {
"auth_ref": [
"r165",
"r222",
"r267"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 2.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
"label": "Research and development"
}
}
},
"localname": "ResearchAndDevelopmentExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r19",
"r151",
"r162",
"r221",
"r250",
"r262",
"r264"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 4.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Accumulated deficit",
"negatedLabel": "Accumulated deficit"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/GoingConcernDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
"r0",
"r80",
"r81",
"r82",
"r84",
"r89",
"r91",
"r123",
"r159",
"r160",
"r161",
"r167",
"r168",
"r192",
"r259",
"r261"
],
"lang": {
"en-us": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings [Member]"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
"auth_ref": [
"r101",
"r102",
"r108",
"r112",
"r113",
"r117",
"r118",
"r119",
"r152",
"r153",
"r223"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 1.0,
"parentTag": "us-gaap_GrossProfit",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
"label": "SALES",
"verboseLabel": "Net sales"
}
}
},
"localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative",
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Cash received on stock transaction after deduction of issuance costs.",
"label": "Stock sold per affiliate agreement"
}
}
},
"localname": "SaleOfStockConsiderationReceivedOnTransaction",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
"label": "Stock sold per affiliate agreement, shares"
}
}
},
"localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
"auth_ref": [
"r214",
"r215"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Schedule of Related Party Transactions, by Related Party [Table]"
}
}
},
"localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShareBasedCompensation": {
"auth_ref": [
"r69"
],
"calculation": {
"http://advbiomed.com/role/StatementsOfCashFlows": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss": {
"order": 5.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of noncash expense for share-based payment arrangement.",
"label": "Stock-based compensation expenses"
}
}
},
"localname": "ShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows",
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
"label": "Shares, Outstanding",
"periodEndLabel": "Ending balance, shares",
"periodStartLabel": "Beginning balance, shares"
}
}
},
"localname": "SharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r0",
"r33",
"r46",
"r47",
"r48",
"r80",
"r81",
"r82",
"r84",
"r89",
"r91",
"r98",
"r123",
"r150",
"r151",
"r159",
"r160",
"r161",
"r167",
"r168",
"r192",
"r197",
"r198",
"r199",
"r200",
"r201",
"r203",
"r259",
"r260",
"r261",
"r287"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Statement of Financial Position [Abstract]"
}
}
},
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [
],
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
"r80",
"r81",
"r82",
"r98",
"r223"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/PrinciplesOfConsolidationDetailsNarrative",
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
"auth_ref": [
"r16",
"r17",
"r151"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
"label": "Stock issued in acquisition, shares"
}
}
},
"localname": "StockIssuedDuringPeriodSharesAcquisitions",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
"label": "Shares issued for services, shares"
}
}
},
"localname": "StockIssuedDuringPeriodSharesIssuedForServices",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
"label": "Shares issued for services"
}
}
},
"localname": "StockIssuedDuringPeriodValueIssuedForServices",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r17",
"r21",
"r22",
"r75",
"r120",
"r122",
"r195",
"r221"
],
"calculation": {
"http://advbiomed.com/role/BalanceSheets": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"periodEndLabel": "Ending balance, value",
"periodStartLabel": "Beginning balance, value",
"totalLabel": "Total stockholders\u2019 deficit"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets",
"http://advbiomed.com/role/StatementsOfStockholdersDeficit"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "STOCKHOLDERS\u2019 DEFICIT"
}
}
},
"localname": "StockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/BalanceSheets"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
"auth_ref": [
"r2"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
"label": "GOING CONCERN"
}
}
},
"localname": "SubstantialDoubtAboutGoingConcernTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/GoingConcern"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-us": {
"role": {
"label": "Supplemental of cash flow information"
}
}
},
"localname": "SupplementalCashFlowInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfCashFlows"
],
"xbrltype": "stringItemType"
},
"us-gaap_TypeOfArrangementAxis": {
"auth_ref": [
"r175"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
"label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
}
}
},
"localname": "TypeOfArrangementAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/OrganizationDetailsNarrative"
],
"xbrltype": "stringItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r94",
"r97"
],
"lang": {
"en-us": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Weighted average number of shares outstanding during the period - diluted"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
"auth_ref": [
"r92",
"r93"
],
"lang": {
"en-us": {
"role": {
"documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
"label": "Weighted average number of shares outstanding during the period - in issue"
}
}
},
"localname": "WeightedAverageNumberOfSharesIssuedBasic",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r92",
"r97"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Weighted average number of shares outstanding during the period - basic"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://advbiomed.com/role/StatementsOfOperationsAndComprehensiveLoss"
],
"xbrltype": "sharesItemType"
}
},
"unitCount": 4
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "105",
"URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(12))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r100": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "275",
"URI": "http://asc.fasb.org/topic&trid=2134479"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(13))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "42",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(14))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
},
"r121": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "440",
"URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "440",
"URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(15))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r130": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "440",
"URI": "http://asc.fasb.org/topic&trid=2144648"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
},
"r132": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "450",
"URI": "http://asc.fasb.org/topic&trid=2127136"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(i))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(ii))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iv))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(5))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(16))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(i))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iv))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(5))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "1F",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "69E",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "69F",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(17))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(n)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "80",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r161": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(g)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
},
"r164": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "730",
"URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(3)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r169": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I.7)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "808",
"URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(2)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r182": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r183": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c),(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "4J",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "4K",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "4M",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
},
"r191": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "810",
"URI": "http://asc.fasb.org/topic&trid=2197479"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)(3)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
},
"r197": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r2": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "40",
"Topic": "205",
"URI": "http://asc.fasb.org/subtopic&trid=51888271"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(4))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(c)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r202": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
},
"r205": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
},
"r207": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(1)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
},
"r209": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r215": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
},
"r217": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "850",
"URI": "http://asc.fasb.org/topic&trid=2122745"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r221": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
},
"r222": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "730",
"Topic": "912",
"URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.L)",
"Topic": "924",
"URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
},
"r224": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
},
"r226": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
},
"r227": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
},
"r228": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
},
"r231": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
},
"r233": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(1)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(2)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
},
"r236": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "20",
"Topic": "940",
"URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
},
"r237": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r239": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03.17)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(7))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(15))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r241": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r242": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(26))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04.9)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "235",
"Subparagraph": "(SX 210.9-05(b)(2))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "360",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
},
"r247": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "505",
"Subparagraph": "(c)(1)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=117337116&loc=SL5958568-112826"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(8))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(8))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03.(a),19)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r254": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(19))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r256": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(22))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(8))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(9))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.1)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(1)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(i)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(ii)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(h)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "440",
"Subparagraph": "(a)",
"Topic": "954",
"URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Footnote 4))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
},
"r267": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "985",
"URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
},
"r268": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r269": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-23"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.13)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r270": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r271": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "g"
},
"r272": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12, 13, 15d"
},
"r273": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "13e",
"Subsection": "4c"
},
"r274": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "14d",
"Subsection": "2b"
},
"r275": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "15",
"Subsection": "d"
},
"r276": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "14a",
"Subsection": "12"
},
"r277": {
"Name": "Form 10-K",
"Number": "249",
"Publisher": "SEC",
"Section": "310"
},
"r278": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "308",
"Subsection": "a"
},
"r279": {
"Name": "Form 20-F",
"Number": "249",
"Publisher": "SEC",
"Section": "220",
"Subsection": "f"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.14)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r280": {
"Name": "Form 40-F",
"Number": "249",
"Publisher": "SEC",
"Section": "240",
"Subsection": "f"
},
"r281": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1"
},
"r282": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r283": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r284": {
"Name": "Securities Act",
"Number": "230",
"Publisher": "SEC",
"Section": "425"
},
"r285": {
"Name": "Securities Act",
"Number": "7A",
"Publisher": "SEC",
"Section": "B",
"Subsection": "2"
},
"r286": {
"Name": "Securities Act",
"Number": "Section",
"Publisher": "SEC",
"Section": "12"
},
"r287": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(a)(3)(iii)(03)",
"Topic": "848"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r3": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "205",
"URI": "http://asc.fasb.org/topic&trid=2122149"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.25)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.6(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "14A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(210.5-03(11))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(10))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(21))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(24))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.1,2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7(b))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.8)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.9)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(k)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.12-04(a))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
},
"r79": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(10))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(11))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
}
},
"version": "2.1"
} |
